C M Bidwell & Associates LTD Chinook Therapeutics, Inc. Transaction History

C M Bidwell & Associates LTD

  • $148 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$21.53 - $26.8 $196,977 - $245,193
-9,149 Reduced 85.99%
1,490 $34,000
Q3 2022

Nov 14, 2022
BUY
$17.51 - $23.37 $23,620 - $31,526
1,349 Added 14.52%
10,639 $209,000
Q2 2022

Aug 12, 2022
BUY
$12.59 - $18.8 $116,961 - $174,652
9,290 New
9,290 $162,000

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email